Beyond Air Reports Q3 2026 Financials & Corporate Update
13 Feb 2026 //
GLOBENEWSWIRE
XTL Update On Recent Developments
29 Jan 2026 //
GLOBENEWSWIRE
XTL Bio Acquires 85% Beyond Air`s Neuronos, Enters Autism Market
13 Jan 2026 //
GLOBENEWSWIRE
FDA Grants NeuroNOS Orphan Drug Status for Glioblastoma in Adults
08 Sep 2025 //
GLOBENEWSWIRE
NeuroNOS Receives FDA Orphan Designation for Phelan-McDermid
21 Apr 2025 //
GLOBENEWSWIRE
NeuroNOS Appoints Nobel Laureate Dan Shechtman to Advisory Board
15 Apr 2025 //
GLOBENEWSWIRE
NeuroNOS CSO Publishes Research on Alzheimer`s Mechanism
01 Apr 2025 //
GLOBENEWSWIRE
NeuroNOS Secures $2.0M for Autism Therapy Development
24 Mar 2025 //
GLOBENEWSWIRE
NeuroNOS Appoints Nobel Laureate Roger to Scientific Advisory Board
26 Nov 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support